Clinical Trials Browser

Withdrawn × Recurrence × Nivolumab × Clear all

NCT02962804 2018-03-05

Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent Renal Cell Carcinoma (RCC)

Phase 2 Withdrawn

Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms, Recurrence